PP
NNVC icon

Paloma Partners’s NanoViricides NNVC Stock Holding History

Paloma Partners’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-730
Closed -$3K – 1849
2018
Q4 		$3K Buy
+730
New +$4.67K ﹤0.01% 1212
2015
Q3 		– Sell
-3,305
Closed -$114K – 1807
2015
Q2 		$114K Buy
+3,305
New +$126K ﹤0.01% 1661

Other funds holding NNVC

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PTB
Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SCA
STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

Paloma Partners's NNVC Position: Q1 2019 in Review

Paloma Partners sold out of NanoViricides (NNVC) in Q1 2019, closing a stake of 730 shares — an estimated $3K sold.

Paloma Partners first reported a position in NNVC in Q2 2015 and held it in 2 quarters. The position peaked at $114K in Q2 2015. 39 funds tracked by Wall St. Rank hold NNVC as of Q1 2019.

  • Paloma Partners reported no remaining NanoViricides position as of Q1 2019 after selling out during the quarter.
  • Paloma Partners sold 730 NanoViricides shares in Q1 2019, an estimated $3K.
  • Paloma Partners first reported a position in NanoViricides in Q2 2015 and held it in 2 quarters.
  • Paloma Partners's NanoViricides position peaked at $114K in Q2 2015.
  • 39 funds tracked by Wall St. Rank held NanoViricides as of Q1 2019.

Based on Paloma Partners's 13F filing for Q1 2019, filed 15 May 2019.